Sai Life Sciences Announces Q3FY26 Results: Revenue Up By 43%, EBITDA Up By 79%, Net Profit Up By 199%

Sai Life Sciences Limited, a leading Contract Research, Development and Manufacturing Organizations (CRDMO), has announced its financial results for the third quarter and nine months ended December 2025. The company reported a significant increase in revenue, EBITDA, and net profit. The revenue from operations was INR 556 crores for Q3FY26, a 27% year-on-year increase. EBITDA stood at INR 191 crores for Q3FY26, a 54% year-on-year increase. The net profit stood at INR 100 crores for Q3FY26, an 86% year-on-year increase. For the nine months ended December 2025, the revenue from operations was INR 1,590 crores, a 43% year-on-year increase. The EBITDA stood at INR 472 crores, a 79% year-on-year increase. The net profit stood at INR 245 crores, a 199% year-on-year increase.